Founders

KEW Group’s Founders

We have an outstanding group of founders with healthcare and business expertise to design, develop, and manage a national network of community cancer care centers.

Raju Kucherlapati, PhD
Raju Kucherlapati, PhD – KEW Board Chair. Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School; Founder of Millennium and Abgenix; Member, U.S. Institute of Medicine
Kathy Behrens Wilsey
Kathy Behrens Wilsey, PhD – KEW Board Member. Former Partner, Robertson Stephens Investments; President of the National Venture Capital Association; Member of PCAST
Jeff Elton, PhD
Jeff Elton, PhDKEW founder and Board Member. Former Global COO & Strategy Head for the Novartis Institutes for BioMedical Research; McKinsey Partner in Health Care, Life Sciences
Bruce Johnson, MD
Bruce Johnson, MD – Thoracic Oncology, Dana Farber Cancer Center; Professor of Medicine, Harvard Medical School
Bob Horvitz, PhD
Bob Horvitz, PhD – Kew Board Observer. Investigator Howard Hughes Medical Institute; MIT Institute Professor; MIT Center for Cancer Research; Nobel Prize in Medicine 2002
John Glaser, PhD
John Glaser, PhD - CEO of Siemens Information Technologies; former CIO of Partners Healthcare and Advisor to the Obama administration; winner of John Gall award for Healthcare CIO of the year 2009
Mason Freeman, MD
Mason Freeman, MD - Professor of Medicine, MGH & Harvard Medical School, Head of the MGH Center for Translational Medicine, former head of Translational Medicine for Cardiovascular Metabolism, Novartis
Clayton Christensen, PhD
Clayton Christensen, PhD - Robert James Cizik Professor of Business Administration, Harvard Business School; author of “Innovator’s Prescription” 2009
Richard Bohmer, MD
Richard Bohmer, MD - Senior Lecturer, Harvard Business School, author of “Designing Care: Aligning the Nature and Management of Health Care” (HBS Press, 2009); former MGH Clinical Improvement leader
Viren Mehta, PhD
Viren Mehta, PhD - Founder and managing member of Mehta Partners, LLC